These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9508378)

  • 1. Malignant melanoma staging using whole-body positron emission tomography.
    Paquet P; Hustinx R; Rigo P; Piérard GE
    Melanoma Res; 1998 Feb; 8(1):59-62. PubMed ID: 9508378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
    Böni R; Böni RA; Steinert H; Burg G; Buck A; Marincek B; Berthold T; Dummer R; Voellmy D; Ballmer B
    Br J Dermatol; 1995 Apr; 132(4):556-62. PubMed ID: 7748746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography for staging and management of malignant melanoma.
    Prichard RS; Hill AD; Skehan SJ; O'Higgins NJ
    Br J Surg; 2002 Apr; 89(4):389-96. PubMed ID: 11952577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planar coincidence scintigraphy and PET in staging malignant melanoma.
    Steinert HC; Voellmy DR; Trachsel C; Bicik I; Buck A; Huch RA; von Schulthess GK
    J Nucl Med; 1998 Nov; 39(11):1892-7. PubMed ID: 9829578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma: diagnostic value of F-18 FDG positron emission tomography].
    Aigner RM; Schwarz T; Richtig E
    Wien Med Wochenschr; 2002; 152(11-12):286-8. PubMed ID: 12138657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
    Eigtved A; Andersson AP; Dahlstrøm K; Rabøl A; Jensen M; Holm S; Sørensen SS; Drzewiecki KT; Højgaard L; Friberg L
    Eur J Nucl Med; 2000 Jan; 27(1):70-5. PubMed ID: 10654150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
    Krug B; Dietlein M; Groth W; Stützer H; Psaras T; Gossmann A; Scheidhauer K; Schicha H; Lackner K
    Acta Radiol; 2000 Sep; 41(5):446-52. PubMed ID: 11016764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 13. 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
    Stas M; Stroobants S; Dupont P; Gysen M; Hoe LV; Garmyn M; Mortelmans L; Wever ID
    Melanoma Res; 2002 Oct; 12(5):479-90. PubMed ID: 12394190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
    Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
    Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
    J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
    J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
    Rinne D; Baum RP; Hör G; Kaufmann R
    Cancer; 1998 May; 82(9):1664-71. PubMed ID: 9576286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
    Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
    J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.